These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10940144)

  • 1. Postmenopausal estrogen therapy and depressive symptoms in older women.
    Whooley MA; Grady D; Cauley JA
    J Gen Intern Med; 2000 Aug; 15(8):535-41. PubMed ID: 10940144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.
    Cauley JA; Seeley DG; Ensrud K; Ettinger B; Black D; Cummings SR
    Ann Intern Med; 1995 Jan; 122(1):9-16. PubMed ID: 7985914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project.
    Rice MM; Graves AB; McCurry SM; Gibbons LE; Bowen JD; McCormick WC; Larson EB
    Arch Intern Med; 2000 Jun; 160(11):1641-9. PubMed ID: 10847257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between depressive symptoms and mortality in older women. Study of Osteoporotic Fractures Research Group.
    Whooley MA; Browner WS
    Arch Intern Med; 1998 Oct; 158(19):2129-35. PubMed ID: 9801180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of hormone therapy and depression in community-dwelling elderly women: the Three City Study.
    Scali J; Ryan J; Carrière I; Dartigues JF; Tavernier B; Ritchie K; Ancelin ML
    J Clin Psychiatry; 2010 Dec; 71(12):1673-9. PubMed ID: 20816026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen plus progestin on health-related quality of life.
    Hays J; Ockene JK; Brunner RL; Kotchen JM; Manson JE; Patterson RE; Aragaki AK; Shumaker SA; Brzyski RG; LaCroix AZ; Granek IA; Valanis BG;
    N Engl J Med; 2003 May; 348(19):1839-54. PubMed ID: 12642637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.
    Hlatky MA; Boothroyd D; Vittinghoff E; Sharp P; Whooley MA;
    JAMA; 2002 Feb; 287(5):591-7. PubMed ID: 11829697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study.
    Fung MM; Poddar S; Bettencourt R; Jassal SK; Barrett-Connor E
    Menopause; 2011 Jun; 18(6):629-37. PubMed ID: 21326121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study.
    Jonas HA; Kronmal RA; Psaty BM; Manolio TA; Meilahn EN; Tell GS; Tracy RP; Robbins JA; Anton-Culver H
    Ann Epidemiol; 1996 Jul; 6(4):314-23. PubMed ID: 8876842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hormone therapy and incident gout: population-based case-control study.
    Bruderer SG; Bodmer M; Jick SS; Meier CR
    Menopause; 2015 Dec; 22(12):1335-42. PubMed ID: 25968834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
    Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
    Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.
    Grodstein F; Stampfer MJ; Manson JE; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1996 Aug; 335(7):453-61. PubMed ID: 8672166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.